Koers PURE Bioscience, Inc. Other OTC
Aandelen
PURE
US74621T2096
Huishoudelijke producten
Omzet 2022 | 1,85 mln. 1,71 mln. | Omzet 2023 | 1,88 mln. 1,73 mln. | Marktkapitalisatie | 9,51 mln. 8,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,77 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,77 mln. | EV/omzet 2022 | 10,2 x |
Nettoliquiditeiten 2022 | 3,39 mln. 3,13 mln. | Nettoliquiditeiten 2023 | 74K 68,36K | EV/omzet 2023 | 5,03 x |
K/w-verhouding 2022 |
-5,08
x | K/w-verhouding 2023 |
-2,39
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 59,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08-02-23 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01-01-04 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08-02-23 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09-05-11 |
Tom Lee
BRD | Director/Board Member | 75 | 24-10-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,92% | 38,21 mld. | |
+11,65% | 26,06 mld. | |
-13,60% | 6,82 mld. | |
+1,56% | 5,78 mld. | |
-7,77% | 2,9 mld. | |
-2,64% | 2,2 mld. | |
+2,55% | 2,07 mld. | |
+22,31% | 914 mln. | |
+5,80% | 658 mln. |